Lange C F
Department of Microbiology & Immunology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153 3304, USA.
Autoimmunity. 1994;19(3):179-91. doi: 10.3109/08916939408995693.
Six different hybridomas secreting anti-SCM mAb and one control mAb were placed into adult mice along with [14C] amino acids for biosynthetically labeling. After sacrifice, the 14C mAb ascites along with serum, heart, kidney, lung and skeletal muscle were recovered. Tissue associated specific radio-activity (SpAc) and microscopic structural analyses were performed. Confirmation of mAb specificity was by both immunodot blots as well as Western blot analysis. Peritoneal injection of measured doses of anti-SCM mAb yielded tissue SpAc confirming their in vitro specificities. Two of the mAb showed strong reactivity to both renal (GBM) and lung basement membrane (LBM), two were mainly GBM reactive and two showed polyreactivity with a marked reactivity to a Z-line antigen. Autoradiographic light microscopy confirmed that the anti-SCM mAbs bound to both GBM and LBM and to Z-line antigen. Titrated doses of the mAb yielded autoradiographic confirmation in which the grain number on the GBM and LBM increased with increasing dose of mAb for all mAb except the control. This effect was not seen in the muscle tissues but anatomical localization at the Z-line was consistent. The major significance of these studies is the demonstration that circulating antibodies to SCM can react in vivo with normal mammalian antigens adding confirmation to the in vitro specificity of these cross-reactive anti-SCM mAbs.
将六种分泌抗SCM单克隆抗体(mAb)的不同杂交瘤和一种对照mAb与[14C]氨基酸一起注入成年小鼠体内,用于生物合成标记。处死后,回收含14C的mAb腹水以及血清、心脏、肾脏、肺和骨骼肌。进行了组织相关特异性放射性(SpAc)和微观结构分析。通过免疫斑点印迹以及蛋白质印迹分析来确认mAb的特异性。腹腔注射一定剂量的抗SCM mAb后,组织SpAc证实了它们在体外的特异性。其中两种mAb对肾基底膜(GBM)和肺基底膜(LBM)均表现出强烈反应,两种主要对GBM有反应,另外两种表现出多反应性,对Z线抗原具有明显反应。放射自显影光学显微镜证实,抗SCM mAb与GBM、LBM以及Z线抗原均有结合。滴定剂量的mAb产生了放射自显影证实结果,除对照外,所有mAb的GBM和LBM上的颗粒数均随mAb剂量增加而增加。在肌肉组织中未观察到这种效应,但在Z线处的解剖定位是一致的。这些研究的主要意义在于证明,针对SCM的循环抗体在体内可与正常哺乳动物抗原发生反应,进一步证实了这些交叉反应性抗SCM mAb在体外的特异性。